Prostate cancer will affect about 1 in 8 men. Options for surgery, radiation, and pharmacologic therapy intended to prevent disease progression can have dramatic effects on urinary and bowel function, body image, and sexuality. The optimal management strategy must balance risk and benefit, and it varies from patient to patient.
In this episode of Care Cues, Dr Kelvin Moses and nurse practitioner Meredith Donahue, from Vanderbilt University Medical Center in Nashville, Tennessee, discuss the challenges they face when communicating treatment options with their prostate cancer patients.
The colleagues examine how a shared decision-making process that directly involves the patient and his family can lead to more positive outcomes.
They also discuss how cultural considerations often play a role in the way that patients prefer to manage their disease, and how side-effect tolerance varies between patients and can also affect treatment options and decisions.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Care Cues: Shared Decision-Making in Prostate Cancer - Medscape - Jul 05, 2022.